SECURE MEDICAL RESPONSE TEAMS LTD

Executive Summary

Secure Medical Response Teams Ltd is a micro-sized, recently established company with ongoing negative equity and working capital deficits, indicating weak financial health and liquidity. The company’s current financial profile does not support new credit facilities, and substantial improvement in solvency and cash flow metrics is needed before reconsidering credit exposure. Close monitoring of future financial performance and capital structure changes is essential.

SECURE MEDICAL RESPONSE TEAMS LTD - Analysis Report

Company Number: 14080809

Analysis Date: 2025-07-20 15:41 UTC

1. Credit Opinion: DECLINE
   Secure Medical Response Teams Ltd shows a persistently negative net asset position (£-11,892 as of May 2024) and net current liabilities of nearly £12k, indicating a weak balance sheet with insufficient working capital. The company is very young (incorporated 2022) and micro-sized with only one employee on average, suggesting limited operational scale and financial resilience. The absence of audit and limited financial disclosures restrict confidence in financial stewardship. Given the ongoing negative equity and working capital deficits, the company currently lacks the financial strength and liquidity to reliably service debt obligations or withstand economic stress.

2. Financial Strength:
   The company’s fixed assets are negligible (£66), and current liabilities exceed current assets by a significant margin, resulting in negative net current assets for multiple years. Shareholders’ funds remain negative and have deteriorated since inception. No reported profitability or retained earnings are evident. These factors point to an undercapitalized entity with poor solvency metrics and a tenuous financial structure.

3. Cash Flow Assessment:
   Negative net current assets imply strained short-term liquidity. No cash or cash equivalents figures are provided, but the working capital deficit suggests an inability to meet immediate liabilities from operating cash flow. The company’s reliance on directors’ funding or external support is likely. Without positive cash flow or capital injections, the company is not positioned to cover ongoing expenses or debt repayments.

4. Monitoring Points:

• Improvement in net assets and working capital position
• Evidence of positive operational cash flow or profitability in future accounts
• Any capital injections or shareholder loans to strengthen liquidity
• Director changes or indications of restructuring efforts
• Timeliness and completeness of future filings to assess financial transparency